Evidence map›Paper›PMID 36744383›Full record

ArticleActa psychiatrica Scandinavica2023

Factors associated with early and late response to electroconvulsive therapy.

Kamber L Hart, Thomas H McCoy, Michael E Henry, Stephen J Seiner, James Luccarelli

Open access · bronzeAbstract read
In one paragraph

Article in Acta psychiatrica Scandinavica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?The international journal of neuropsychopharmacology · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kamber L HartDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Thomas H McCoyDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Michael E HenryDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Stephen J SeinerDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
James LuccarelliDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-1606-3917
Harvard University · US

Funding

Dysregulation of Appetitive & Aversive Amygdala Circuits in Bipolar DisorderR01MH120991 · NIMH · MCLEAN HOSPITAL · PI BERRETTA, SABINA, MCCARROLL, STEVEN ANDREW · 2020 to 2024
$4.0M
A Transdiagnostic Assessment of Electroconvulsive Therapy Modulation of Anhedonia and Reward circuitry: Targets, Biomarkers and Predictors of ResponseR01MH112737 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI CAMPRODON, JOAN A · 2017 to 2021
$3.8M
Translational Neuroscience Training for CliniciansT32MH112485 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BUCKNER, RANDY L, ROFFMAN, JOSHUA LAWRENCE · 2018 to 2022
$1.7M
NIMH NIH HHS R01 MH112737NIMH NIH HHS R01 MH120991NIMH NIH HHS T32 MH112485
6 · The paper itself

Abstract

objectiveElectroconvulsive therapy (ECT) is an effective treatment for severe depressive symptoms, yet more research is needed to examine predictors of treatment response, and factors associated with response in patients not initially improving with treatment. This study reports factors associated with time to response (early vs. late) to ECT in a real-world setting.

methodsThis was a retrospective, single-center cohort study of patients endorsing moderate to severe depressive symptoms using the Quick Inventory of Depressive Symptomatology (QIDS; QIDS>10). Response was defined as 50% or greater decrease in QIDS score from baseline. We used logistic regression to predict response at treatment #5 (early response) as well as after treatment #5 (late response) and followed patients through ECT discontinuation or through treatment #20.

resultsOf the 1699 patients included in this study, 555 patients (32.7%) responded to ECT treatment at treatment #5 and 397 (23.4%) responded after treatment #5. Among patients who did not respond by treatment #5, those who switched to brief pulse width ECT from ultrabrief pulse ECT had increased odds of response after treatment #5 compared with patients only receiving ultrabrief pulse (aOR = 1.55, 95% CI: 1.16-2.07). Additionally, patients with less improvement in QIDS from baseline to treatment #5 had decreased odds of response after treatment #5 (aOR = 0.97, 95% CI = 0.97-0.98).

conclusionAmong depressed patients treated with ECT, response occurred in 56.0% of patients by treatment #20. Patient receiving ultrabrief pulse ECT at baseline and who did not respond by treatment #5 had greater odds of subsequent response if switched to brief pulse ECT than if continued with ultrabrief pulse.

Indexed as

Electroconvulsive TherapyTreatment OutcomeAdultDemographyFemaleHumansLogistic ModelsMaleMiddle AgedPrognosisRetrospective StudiesTime Factorsaffective disorderscohort studieselectroconvulsive therapyreal world evidence

Identifiers

PMID36744383
PMCPMC10038910
OpenAlexW4319293942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.